A B S T R A C T We have studied block of L-type calcium channels by intracellular and extracellular application of the ionized dihydropyridine derivatives amlodipine and SDZ 207-180. We find that extracellular application of either drug causes voltagedependent block of calcium channels. However, neither drug is effective when applied intracellularly. The insensitivity of calcium channels to intracellular drug is not due to the low concentrations of cytosolic calcium, because voltage-dependent block by ionized amlodipine, SDZ 207-180, and the neutral drug nisoldipine persists under conditions in which Ca 0 is buffered by EGTA. In fact, the time course of the development of block by the ionized but not neutral drug molecules studied, is slower in the presence than in the absence of calcium. Our results indicate that the DHP binding site of the L-type calcium channel is close to the extracellular surface of the cell membrane and that ionized DHP molecules may interact with the receptor in a manner that is uniquely affected by calcium.
INTRODUCTION
Specific 1,4-dihydropyridine (DHP) ligands have been used as key molecular probes of L-type calcium channels and as powerful therapeutic tools to treat a wide range of cardiovascular disorders (reviewed by Janis and Triggle, 1990) . These compounds have been used to isolate and purify the channel protein (Flockerzi et al., 1986 ; reviewed by Catterall, 1988; Hosey and Lazdunski, 1988 ). DHP's bind with high affinity to the ~-subunit of the DHP receptor protein (Galizzi et al., 1986; Sharp et al., 1987; Sieber et al., 1987) . However, although the primary structures of rabbit skeletal and heart muscle DHP receptors have been cloned (Tanabe et al., 1987; Mikami et al., 1989) and functional activity of the L-type calcium channel has been expressed (Tanabe et al., 1988; Mikami et al., 1989; Perez-Reyes et al., 1989 ) from the cloned cDNAs, the molecular identity and location of the DHP binding site have not yet been determined.
We have shown previously that the charged form of amlodipine, a tertiary DHP molecule, is useful as a probe for the location of the DHP binding site in the cell membrane (Kass and Arena, 1989) . In the present investigation we have used a combination of charged and neutral DHP compounds to test whether the DHP binding site, like that for phenylalkamines, is accessible from the inner surface of the cell membrane. We have determined whether block of monovalent ions, like divalent ions, is voltage dependent; and, additionally, have investigated the dependence of channel block on the absence or presence of calcium.
METHODS
Single ventricular myocytes were isolated from either ventricle of adult guinea pigs using a method similar to that of Mitra and Morad (1985) which has been previously described (Arena and Kass, 1988) .
Recording methods were as described by Hamill et al. ( 1981 ) for the whole cell configuration. Patch pipettes were made from Gold Seal Accu-fill 90 Micropets (Clay Adams, Inc., Parsippany, NJ). The resistance of the pipettes was typically 1-3 MI~ when filled with 140 mM CsC1. Series resistance compensation was used in all experiments and was adjusted to give the fastest possible capacity transients without producing ringing. Membrane currents were measured with and voltage was controlled by either a Yale Mark IV (fabricated in this laboratory from parts available at New Haven, CT) or an Axopatch 1C (Axon Instruments, Inc., Foster City, CA) voltage clamp. Cell capacitance was determined directly by capacity compensation of these circuits. Data were sampled once every 0.3 ms and filtered at 1-2 kHz with an eight pole Bessel filter (Frequency Devices, Inc., Haverhill, MA). In experiments designed to dialyze cells with drug-containing solutions, pipette resistances were chosen to be < 2 MI~ and drugs were added to the intracellular solutions at the concentrations indicated for each experiment.
Solutions and Drugs
Solutions were chosen to eliminate K channel currents. Thus, the standard pipette solution contained in millimolar: 60 CsCI, 50 aspartic acid, 68 CsOH, 1 MgCI 2, 1 CaCl z, N, N', N'tetraacetic acid (EGTA) , 5 K~TP, 10 HEPES (pH 7.4). The standard bath solution contained: 130 mM NaCI, 4.8 CsCI, 5 glucose, 5 HEPES (pH 7.4). In experiments designed to measure divalent ion currents, 2 mM MgClz and divalent charge carriers at indicated concentrations were added to the basic solution. In experiments designed to measure monovalent currents the following were added to the basic extracellular solution: 2 EGTA plus 50 ~M MgCI 2 (for the measurement of Na currents) or 2 ethylenediaminetetraacetic acid (EDTA) and 500 ~M MgCI z (for the measurement of outward currents). Sodium channels were eliminated by 10-50 p~M tetrodotoxin (TTX) (Behring Diagnostics, LaJolla, CA) and by replacement of Na by N-methyl-n-glucamine in some experiments.
The structures of the three DHP compounds used in this study are shown in Fig. 1 . Nisoldipine and SDZ-207-180 were dissolved in polyethylene glycol 400 (PEG) to make a concentrated (1 raM) stock and diluted in the bath to the final concentration. PEG at the concentration used (<0.01%) has been shown to have no effects of its own on Ca channel currents (Kass, 1982) . Amlodipine was dissolved in water as a concentrated (1 raM) stock solution. Amlodipine concentrations were chosen as previously described (Burges et al., 1985 (Burges et al., , 1987 Kass and Arena, 1989) . SDZ-207-180 was a gift of Sandoz, Ltd., Basle, Switzerland; nisoldipine was a gift from Miles Laboratories, New Haven, CT; and amlodipine was a gift from Pfizer Central Research, Sandwich, UK.
Voltage Protocols
Membrane potential regulates DHP modulation of/ca: block is promoted at positive voltages and relieved at negative voltages (for example, see Sanguinetti and Kass, 1984) . The time course of the development or removal of block can be determined by applying a series of test voltages from different holding potentials. In the present study voltage protocols described in detail and illustrated in Kass and Arena (1989) were used to determine onset and recovery of block. Drug onset was measured by applying a depolarizing "train" protocol in which the holding potential was changed from -80 to -40 or -50 mV and test voltage pulses were applied once every 5 s. Test voltages were either 0 mV (Na + currents), + 10 mV (Ca z+ and Ba 2+ currents), or +40 to +60 mV (Cs ÷ and K ÷ currents) and test pulse duration was 200 ms. This protocol was previously shown to maximize the onset of voltage-dependent block by ionized DHP compounds (Kass and Arena, 1989) . After development of block recovery was measured using train protocols in which the holding potential was changed from -40 to -80 mV and pulses were applied to the same test potentials, but test pulse duration was either 20 or 40 ms to minimize pulse-induced inactivation. In experiments that required recording currents from potentials negative to -60 mV, 50-100-ms prepulses were applied to -40 mV to inactivate sodium channel and T-type calcium channel currents (Bean, 1985; Marchetti and Brown, 1988) . Thus, in this paper current referred to as Ca channel current (/ca) corresponds to L-type Ca channel current according to the terminology suggested by Nilius et al. (1985) .
DHP Receptor: Agonism and Antagonism
Most DHP compounds are capable of causing enhancement or block of/Ca depending on cell membrane potential (Hess et al., 1984; Sanguinetti et al., 1986; Kass, 1987) . Binding and electrical data have provided evidence that these effects are due to interactions with more than one binding site (Brown et al., 1986; Kokubun et al., 1986; Wei et al., 1986; Williams et al., 1985; Hamilton et al., 1987) . The binding site probed in this study is associated with inhibition of channel activity. We rarely measured agonistic responses to SDZ 207-180 applied under conditions of negative (-80 to -100 mV) holding potentials, but under similar conditions observed enhancement of currents by amlodipine at pH 7.4 in ~30% of our experiments. Further investigations will be needed to test whether electrical evidence with charged DHP derivatives can support the view that distinct binding sites exist for agonism and antagonism of L-channels.
Curve Fitting and Statistical Procedures
Where appropriate, experimental data were fitted with functions of one or two exponentials plus an arbitrary baseline using procedures previously described (see Sanguinetti and Kass, 1984) . All data in the text and figures are means -+ SEM. T-tests were used to determine statistical significance between groups (Rosner, 1986). Multiple comparisons were made using the pooled estimate of variance from a one-way ANOVA.
RESULTS

The DHP Binding Site Is Accessed from the Outside but Not the Inside of the Cell
To test for an intracellular location of the DHP binding site, we measured the sensitivity of calcium channel current to internal and external application of the permanently charged drug SDZ-207-180. The charge on this compound will restrict it from diffusing out of the cell across the lipid membrane (Hille, 1977) . As a control for internal dialysis, we first measured the effects of internally applied D890, a permanently charged phenylalkamine derivative that has been shown to block I~:~, from the inside of cardiac cells (Heschler et al., 1982; Lee and Tsien, 1984) . We used pulse-dependent block during train protocols to assay drug activity and, as shown in Fig. 2 A, there is a progressive increase in block as this compound diffuses into the cell. In contrast, we found that SDZ 207-180 had little effect when applied internally. This can be seen in Fig. 2 B, which compares pulse-dependent block after 20 min of dialysis with 10 I~M intracellular SDZ 207-180 to a 3-min exposure to 200 nM SDZ 207-180 applied externally to the same cell. We found a similar pattern when we compared intracellular with extracellular application of ionized amlodipine (data not illustrated): currents were only blocked by extracellularly applied drug.
Because of the large size of isolated heart cells, we were concerned that diffusional exchange between the cell interior and patch pipette might be limited within the time frame of our experiments. Rates of diffusional exchange can be estimated for heart cells (Cx ~100 pF) by the methods of Pusch and Neher (1988) . For pipette resistances on the order of 3 MI) (typical for these experiments), and for a molecular mass of 350 D, the diffusion time constant is 15 rain. To confirm the insensitivity of Ic:a to internal application of SDZ 207-180, we compared our results obtained in heart cells with experiments carried out in GH4C1 pituitary tumor cells. These cells are small (mean Cr = 12.65 + 1.2 pF, N = 12) and the predicted diffusional time constant is 40 s (Pusch and Neher, 1988) . For these cells, we found that internally applied D890 (100 IxM) completely blocked lea, consistent with the predictions of Pusch and Neher. However, as was the case for heart cells, Ic, was not blocked by internal SDZ 207-180 in GH4C 1 cells, but was blocked by external drug application (Fig. 3) . Fig. 4 summarizes the results for internal vs. external application of the quaternary DHP for both types of cells. These experiments provide evidence that ionized drug access of the DHP receptor is not via the inner surface of the cell membrane. However, because intracellular calcium is buffered to submicromolar levels in our experiments (Methods), it is possible that the charged DHP molecule is not an effective blocker under these (open bars) and GH4C cells (shaded bars). Internal concentrations were 1-10 ~M in heart (n = 6) and 500 nM in GH4C 1 cells (n = 9). External concentrations were 200 nM in heart (n = 7) and 500 nM for GH4C ] cells (n = 8). (*) Significantly greater than internal application P _< 0.005. conditions. We tested for this possibility by measuring the influence of calcium on the voltage dependence of SDZ 207-180 block. were Ca (squares), Cs (circles), and Na (triangles). The tonic block at start of train protocols for each charge carrier was 13% (Ca), 0% (Na), and 14% (Cs). Calibration bars: 18 ms; 400 pA (Ca), 1.3 nA (Na), and 3.14 nA (Cs). Cells: 11391 (Ca); 111491 (Na); 22AG94 (Cs).
Influence of Calcium on DHP Block and Recovery: Contrast between Neutral and Charged Drugs
Cs ÷ or Na + carry the charge. Interestingly, the development of block is faster when Ca0 is chelated by EGTA. Similar results were obtained with ionized amlodipine. Thus, the ineffectiveness of internally applied SDZ 207-180 and amlodipine is not due to the low concentration of calcium in our intracellular solutions. show currents in response to the first, tenth, and last pulse in each train. The external solution contained 50 I~M Mg +z, and 2 mM EGTA. Pulses were applied at 5 s/pulse as described in Methods. Calcium currents measured in response to the same protocol but with V,e~, = + 10 mV are plotted as solid squares. The Ca data were obtained from cell 7J82. Currents were normalized to the maximum current at the beginning of each train. These current amplitudes were: 5.3 nA (control, Na), 5.01 nA (drug, Na), 3.14 nA (drug, Cs), 813 pA (control, Ca), and 840 pA (drug, Ca).
Neutral Drugs: Nisoldipine
Do neutral and charged DHP compounds share a common sensitivity to conditions in which Ca0 is chelated? We investigated the influence of Ca0 on the voltagedependence of block by the neutral DHP nisoldipine to test this possibility and the results are presented in Fig. 6 . Under conditions in which Ca0 is chelated, block of monovalent currents by nisoldipine is voltage-dependent, and the time course of block onset is affected neither by the marked difference in test pulse voltage nor in the ionic species carrying the charge. However, in contrast to the actions of the ionized molecules, the onset of nisoldipine block is unchanged when Ca0 is not buffered and calcium is the charge carrier.
DISCUSSION
The major new result presented in this paper is that the permanently charged compound SDZ 207-180 and ionized amlodipine are much more potent when applied extracellularly compared with intracellular application. In addition, we find that the development of voltage-dependent block by ionized and neutral DHP molecules persists under conditions when calcium is buffered to micromolar concentrations, but that the onset of block by the two ionized drugs is slower in the presence than in the absence of calcium.
Extracellular Access to the DHP Binding Site
Our experiments in which we compared intracellular and extracellular application of ionized amlodipine and SDZ 207-180 in heart and GH4C1 cells provide evidence that these two charged DHP compounds cannot reach the DHP receptor via an intracellular pathway. This finding contrasts with the accessibility of the permanently charged drug D890 to the phenylalkamine receptor which occurs via an intracellular pathway in guinea pig ventricular cells (Heschler et al., 1982) , but not in vascular smooth muscle cells of the rabbit (Leblanc and Hume, 1989) . Our result is, however, consistent with data reported by Iijima et al. (1984) for intracellular application of the DHP nicardipine. The difference in intracellular accessibility of the two permanently charged drug types supports the view that the binding sites for DHPs and phenylalkamines on the ~l-subunit of the DHP receptor protein are physically separate entities (Glossmann et al., 1984) . Valdivia and Coronado (1990) have reported that SDZ 207-180 can interact with a high affinity DHP binding site when applied to either side of a planar lipid bilayer into which skeletal muscle transverse tubule Ca channels had been incorporated. They suggested that the 10 methylene groups that separate the quaternary ammonium from the DHP ring in this molecule (Fig. 1) are sufficiently long to allow the DHP moiety to be uncharged and reach the DHP binding site through the lipid bilayer regardless of the side of application. If this view is correct, then our results, which show an asymmetrical response in both intact heart and GH4C J cells, suggest that the high affinity DHP binding site is closer to the extracellular membrane face than the intracellular face and is just beyond the reach of the methylene spacer chain when applied from the intracellular side of the membrane. These results are consistent with conclusions reached from investigations of the sensitivity amlodipine to changes in external hydrogen ion concentrations (Kass and Arena, 1989) .
Location of the DHP Binding Site
Calcium Ions Modify Block by Ionized DHP Derivatives
Our results cannot be explained by a change in blocking activity of SDZ 207-180 due to the low levels of intracellular calcium because we find that voltage dependence of block by neutral and ionized DHP molecules is preserved under conditions in which calcium is buffered to micromolar concentrations by either EGTA or EDTA (see also Hess et al., 1986; Hadley and Hume, 1987) . However, under conditions in which calcium is the permeant ion, block by ionized amlodipine and SDZ 207-180 develops at a slower rate than under conditions when Ca0 is buffered and monovalent ions carry the charge. Block by the neutral molecule nisoldipine is not affected by chelating Ca0. Recovery from block by these two ionized DHPs, but not nisoldipine, is also slower when calcium is the charge carrier (data not shown). These results are similar to those of Lux (1988a, b, 1989 ) who reported that t0-Conotoxin (¢o-CTX) blockade of high threshold (L-type) calcium channels differed markedly depending on the type of ion carrying charge through the open channel pore. Those authors suggested that 00-CTX binding was influenced by charge carrier-induced channel conformational changes. Permeating charge species-induced differences in channel conformation are expected since channel permeation is determined by two intrapore binding sites with varying affinity for monovalent and divalent ions (Almers and McCleskey, 1984; Hess et al., 1986) . In fact, Prod'hom et al. (1989) have reported that charge carrier-induced conformational changes underlie the modulation of proton-induced fluctuations in L-channel conductance levels, and suggested that Ca forms a stabilizing complex with the calcium channel protein and limits the flexibility of the channel protein that exists when other ion species permeate the channel. Our results are consistent with this view of the channel, but cannot rule out the possibility that it is an interaction between the charged head groups of amlodipine or SDZ 207-180 with extracellular calcium that interacts with the drug-bound state of the channel. Future experiments with other ionized drug molecules will be useful in distinguishing these possibilities.
SUMMARY
In summary, our results have shown that charged DHP derivatives are very useful as probes of the L-type channel in intact cell membranes. We have found that ionized amlodipine and the permanently charged derivative SDZ 207-180 are useful in determining the location of the DHP binding site that causes inhibition of channel activity. Studies of other DHP derivatives with different charge locations will further define the location of this site and provide insight into possible conformational changes L-channels undergo for varied permeant ions.
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